Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Ottawa

$25,000.00

Detection of protein disease markers using long-range surface plasmon waveguides

EF 2015-16

Résumé
Currently available point-of-care bio-detection systems provide blood analysis results relevant to blood chemistry/electrolytes, hematology, blood gases, coagulation and cardiac markers. The core technology used in commercial systems is based on electrochemical transduction, and although convenient, it is limited in specificity and sensitivity. These limitations preclude market expansion into the detection of markers for many diseases. Thus, there is a strong interest in new detection technologies that will improve sensitivity and specificity of tests carried out at the point of care. The detection of analyte, e.g., cardiac troponin I (c-TnI, a myocardial infarction marker), to low concentration levels is of strong interest. The company-specific problem to be addressed in this project consists of detecting a protein disease marker, such as c-TnI, to low concentrations, initially in clean fluids, then in complex fluids such as blood plasma. Our industrial partner will benefit from this project through the development and application of new bio-detection approaches and technologies to a problem of high relevance to the medical community. Ultimately, transfer of the technology to the partner would lead to expansion into new markets producing economic benefits to Canada.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
488658-2015
Name nom
Berini, Pierre
Department département
Electrical Engineering and Computer Science , School of
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
2505
Research subject group en
Electrical and electronic engineering
Research subject group fr
Génie électrique et électronique
Research subject en
Photon devices
Research subject fr
Dispositifs photoniques
Partie
1
Nb partie
1
Application title
Detection of protein disease markers using long-range surface plasmon waveguides
Keyword
NSERC
Application summary
Currently available point-of-care bio-detection systems provide blood analysis results relevant to blood chemistry/electrolytes, hematology, blood gases, coagulation and cardiac markers. The core technology used in commercial systems is based on electrochemical transduction, and although convenient, it is limited in specificity and sensitivity. These limitations preclude market expansion into the detection of markers for many diseases. Thus, there is a strong interest in new detection technologies that will improve sensitivity and specificity of tests carried out at the point of care. The detection of analyte, e.g., cardiac troponin I (c-TnI, a myocardial infarction marker), to low concentration levels is of strong interest. The company-specific problem to be addressed in this project consists of detecting a protein disease marker, such as c-TnI, to low concentrations, initially in clean fluids, then in complex fluids such as blood plasma. Our industrial partner will benefit from this project through the development and application of new bio-detection approaches and technologies to a problem of high relevance to the medical community. Ultimately, transfer of the technology to the partner would lead to expansion into new markets producing economic benefits to Canada.